[1]杜明亮 王泊然 惠慧 郑晓群.冠状动脉微循环功能障碍临床研究进展[J].心血管病学进展,2023,(8):699.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.007]
 DU Mingliang,WANG Boran,HUI Hui,et al.Clinical Research Progress of Coronary Microcirculation Dysfunction[J].Advances in Cardiovascular Diseases,2023,(8):699.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.007]
点击复制

冠状动脉微循环功能障碍临床研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年8期
页码:
699
栏目:
综述
出版日期:
2023-08-25

文章信息/Info

Title:
Clinical Research Progress of Coronary Microcirculation Dysfunction
作者:
杜明亮 王泊然 惠慧 郑晓群
(大连市中心医院冠心病科,辽宁 大连 116032)
Author(s):
DU MingliangWANG BoranHUI HuiZHENG Xiaoqun
(Department of Coronary Heart Disease,Dalian Central Hospital,Dalian 116032,Liaoning,China)
关键词:
冠状动脉微循环内皮功能障碍冠状动脉血流储备
Keywords:
Coronary microcirculationEndothelial dysfunctionCoronary flow reserve
DOI:
10.16806/j.cnki.issn.1004-3934.2023.08.007
摘要:
冠状动脉微循环功能障碍是缺血性心脏病的一个复杂的组成部分,随着基础研究及诊断技术的发展,该疾病受到越来越多临床医师的关注,现就该疾病的发病机制、诊断及治疗等最新观点做一综述,旨在提高临床医师对该疾病的识别和管理。
Abstract:
Coronary microcirculation dysfunction is a complex component of ischemic heart disease. With the development of basic research and diagnostic techniques,this disease has attracted more and more clinicians’ attention. This paper reviews the latest views on the pathogenesis,diagnosis and treatment of this disease,aiming at improving the recognition and management of this disease by clinicians

参考文献/References:

[1].Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.
[2].Ong P,Camici PG,Beltrame JF,et al. International standardization of diagnostic criteria for microvascular angina[J]. Int J Cardiol,2018,250:16-20.
[3].Kaski JC,Crea F,Gersh BJ,et al. Reappraisal of ischemic heart disease[J]. Circulation,2018,138(14):1463-1480.
[4].Thakker RA,Rodriguez Lozano J,Rodriguez Lozano P,et al. Coronary microvascular disease[J]. Cardiol Ther,2022,11(1):23-31.
[5].段首鹏,江洪,余锂镭. 冠状动脉微循环功能障碍与自主神经研究进展[J]. 心血管病学进展,2022,43(6):495-498.
[6].Del Buono MG,Montone RA,Camilli M,et al. Coronary microvascular dysfunction across the spectrum of cardiovascular?diseases:JACC?state-of-the-art review[J]. J Am Coll Cardiol,2021,78(13):1352-1371.
[7].Padro T,Manfrini O,Bugiardini R,et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’[J]. Cardiovasc Res,2020,116(4):741-755.
[8].Crea F,Montone RA,Rinaldi R. Pathophysiology of coronary microvascular dysfunction[J]. Circ J,2022,86(9):1319-1328.
[9].Camici PG,Tsch?pe C,di Carli MF,et al. Coronary microvascular dysfunction in hypertrophy and heart failure[J]. Cardiovasc Res,2020,116(4):806-816.
[10]. Suda A,Takahashi J,Hao K,et al. Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease[J]. J Am Coll Cardiol,2019,74(19):2350-2360.
[11].Tsai SH,Lu G,Xu X,et al. Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy[J]. Cardiovasc Res,2017,113(11):1329-1337.
[12].Wasserman DH,Wang TJ,Brown NJ. The vasculature in prediabetes[J]. Circ Res,2018,122(8):1135-1150.
[13].Camici PG,Crea F. Coronary microvascular dysfunction[J]. N Engl J Med,2007,356(8):830-840.
[14].Olsen RH,Pedersen LR,Jürs A,et al. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease[J]. Int J Cardiol,2015,185:229-235.
[15]. Rooks C,Faber T,Votaw J,et al. Effects of smoking on coronary microcirculatory function:a twin study[J]. Atherosclerosis,2011,215(2):500-506.
[16]. Hambrecht R,Gielen S,Linke A,et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure:a randomized trial[J]. JAMA,2000,283(23):3095-3101.
[17].Lindahl B,Baron T,Erlinge D,et al. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease[J]. Circulation,2017,135(16):1481-1489.
[18].Vilahur G,Gutiérrez M,Casani L,et al. P2Y12 antagonists and cardiac repair post-myocardial infarction:global and regional heart function analysis and molecular assessments in pigs[J]. Cardiovasc Res,2018,114(14):1860-1870.
[19].Manfrini O,Morrell C,Das R,et al. Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)[J]. Am J Cardiol,2014,113(10):1628-1633.
[20].林谦,吴宗贵,张立晶,等. 冠状动脉微血管疾病中西医结合诊疗专家共识[J]. 中西医结合心脑血管病杂志,2022,20(21):3841-3850.

相似文献/References:

[1]张楠 王萍.松弛素对冠状动脉微循环的影响[J].心血管病学进展,2019,(5):704.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.011]
 ZHANG Nan,WANG Ping.Effects of elaxin on Coronary Microcirculation[J].Advances in Cardiovascular Diseases,2019,(8):704.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.011]
[2]关星绘 孙林.心脏磁共振技术在冠状动脉微循环疾病中的运用进展[J].心血管病学进展,2020,(4):345.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.004]
 GUAN Xinghui,SUN Lin.Application Progress of Cardiac Magnetic Resonance in Coronary Microvascular Disease[J].Advances in Cardiovascular Diseases,2020,(8):345.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.004]
[3]于博文 修成奎 王雪 杨静 雷燕.内皮微粒在临床中的研究进展及应用[J].心血管病学进展,2021,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
 YU Bowen,XIU Chengkui,WANG Xue,et al.Research Progress and Application of Endothelial Microparticles in Clinic[J].Advances in Cardiovascular Diseases,2021,(8):76.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[4]付亚萌 张光明.内质网应激与内皮功能障碍关系及临床治疗研究进展[J].心血管病学进展,2024,(3):243.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.012]
 FU YamengZHANG Guangming.Research progress on the relationship between endoplasmic reticulum stress and endothelial dysfunction and its clinical treatment[J].Advances in Cardiovascular Diseases,2024,(8):243.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.012]

备注/Memo

备注/Memo:
收稿日期:2022-12-14项目基金:大连市中心医院“登峰计划”院内自主立项(2022ZZ228)
更新日期/Last Update: 2023-09-21